company background image
600750 logo

Jiang Zhong PharmaceuticalLtd SHSE:600750 Stock Report

Last Price

CN¥25.37

Market Cap

CN¥15.8b

7D

-3.9%

1Y

18.6%

Updated

14 Jun, 2024

Data

Company Financials +

Jiang Zhong Pharmaceutical Co.,Ltd

SHSE:600750 Stock Report

Market Cap: CN¥15.8b

Jiang Zhong Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiang Zhong PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥25.37
52 Week HighCN¥28.58
52 Week LowCN¥17.50
Beta0.29
1 Month Change-6.97%
3 Month Change10.83%
1 Year Change18.55%
3 Year Change126.32%
5 Year Change132.57%
Change since IPO3,073.14%

Recent News & Updates

A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

May 22
A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

Recent updates

A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

May 22
A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

Apr 15
Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

Shareholder Returns

600750CN PharmaceuticalsCN Market
7D-3.9%-0.7%-0.07%
1Y18.6%-11.9%-15.5%

Return vs Industry: 600750 exceeded the CN Pharmaceuticals industry which returned -11.9% over the past year.

Return vs Market: 600750 exceeded the CN Market which returned -15.5% over the past year.

Price Volatility

Is 600750's price volatile compared to industry and market?
600750 volatility
600750 Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 600750 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600750's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19694,013Wenbin Xiaowww.jzjt.com

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods. It offers OTC products for gastrointestinal digestion, upper respiratory tract, and supplements; protein nutrition, tonics, health regimen, probiotics, daily protection, beauty, bone health, and plant liver protection health products; and prescription products. The company sells its products under the Jiangzhong, Jiangzhong Lihuo, Chuyuan, Shenlingcao, Borlock, Yang Jisheng, and Sanghai brands.

Jiang Zhong Pharmaceutical Co.,Ltd Fundamentals Summary

How do Jiang Zhong PharmaceuticalLtd's earnings and revenue compare to its market cap?
600750 fundamental statistics
Market capCN¥15.81b
Earnings (TTM)CN¥732.52m
Revenue (TTM)CN¥4.27b

21.6x

P/E Ratio

3.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600750 income statement (TTM)
RevenueCN¥4.27b
Cost of RevenueCN¥1.47b
Gross ProfitCN¥2.80b
Other ExpensesCN¥2.07b
EarningsCN¥732.52m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.18
Gross Margin65.50%
Net Profit Margin17.14%
Debt/Equity Ratio0%

How did 600750 perform over the long term?

See historical performance and comparison

Dividends

5.1%

Current Dividend Yield

112%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.